pepmg_

Study summary · research use only

[Immunostimulants--therapeutic aspects]

Review · human · Archiv fur Geschwulstforschung · 1989 · PMID 2493778

Plain-language summary

Paraphrased from the published abstract below — not a verdict on whether anything works.

This survey reviews the known modes of action and therapeutic applications of agents with immunostimulatory effects: Interleukin-2, Interferon-gamma, Tumor necrosis factor, Thymosin alpha 1, Thymopentin, Splenopentin, Thymulin, Thymostimulin, Muramyl dipeptide, Bestatin, Tuftsin, and Levamisole. The abstract states that treatment of patients with immunodeficiency disorders and cancer using such agents appeared possible in the near future.

Abstract

A survey is given about the so far known mode of action and the therapeutic application of the following agents with immunostimulatory effects: Interleukin-2, Interferon-gamma, Tumor necrosis factor, Thymosin alpha 1, Thymopentin, Splenopentin, Thymulin, Thymostimulin, Muramyl dipeptide, Bestatin, Tuftsin and Levamisole. The treatment of patients suffering from immunodeficiency disorders and cancer with such agents seems to be possible in the near future.

Read the full study on PubMed ↗

pepmg summarizes the peer-reviewed literature and links to every source. It sells nothing and ships nothing. Where an FDA label, a peer-reviewed study or a clinical-trial registry entry (labeled trial registry, not peer-reviewed) has published a dose, pepmg reports it with the source named; it gives no personalized recommendations and no administration technique. Don't just trust this summary: follow the citation to its source and read it yourself. Research use only.